{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:11:49Z","timestamp":1772115109366,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jinf.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T19:00:52Z","timestamp":1445626852000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability"],"prefix":"10.1016","volume":"72","author":[{"given":"Mar\u00eda D.","family":"Esteban-Vasallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Felicitas","family":"Dom\u00ednguez-Berj\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Gil de Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenaro","family":"Astray-Mochales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Blanco-Ancos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Gil-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2015.10.003_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12889-015-1514-y","article-title":"The humanistic, economic and societal burden of Herpes Zoster in Europe: a critical review","volume":"15","author":"Gater","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jinf.2015.10.003_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4161\/hv.28620","article-title":"Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)","volume":"10","author":"Esteban-Vasallo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2015.10.003_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s15010-011-0162-0","article-title":"Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study","volume":"39","author":"Hata","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2015.10.003_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s15010-007-6347-x","article-title":"Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel","volume":"36","author":"Heymann","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2015.10.003_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.mayocp.2012.05.021","article-title":"Chronic medical conditions as risk factors for herpes zoster","volume":"87","author":"Joesoef","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jinf.2015.10.003_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jpeds.2013.03.010","article-title":"Increased risk of herpes zoster in children with asthma: a population-based case-control study","volume":"163","author":"Kim","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2015.10.003_bib8","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1503\/cmaj.101137","article-title":"Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study","volume":"183","author":"Yang","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jinf.2015.10.003_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2015.10.003_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1576-9887(11)70020-6","article-title":"Hospitalizaciones por herpes zoster y neuralgia postherp\u00e9tica en la Comunidad de Madrid, 1998\u20132003","volume":"12","author":"de Juanes","year":"2011","journal-title":"Vacunas"},{"key":"10.1016\/j.jinf.2015.10.003_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","article-title":"Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998\u20132004)","volume":"9","author":"Gil","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2015.10.003_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jinf.2015.01.015","article-title":"Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003\u20132013","volume":"71","author":"Esteban-Vasallo","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2015.10.003_bib14","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2015.10.003_bib15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4161\/hv.7.10.16480","article-title":"Immunogenicity and safety of ZOSTAVAX((R)) approaching expiry potency in individuals aged >\/=50 years","volume":"7","author":"Arnou","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jinf.2015.10.003_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2013.09.035","article-title":"Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005\u20132012","volume":"68","author":"Esteban-Vasallo","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2015.10.003_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","article-title":"Different vaccination strategies in Spain and its impact on severe varicella and zoster","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2015.10.003_bib18","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia","volume":"28","author":"Carville","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2015.10.003_bib19","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","article-title":"Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination","volume":"25","author":"Di Legami","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2015.10.003_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib21","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: Burden of disease in France","volume":"28","author":"Gonzalez Chiappe","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2015.10.003_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.20344\/amp.312","article-title":"Hospital admissions for herpes zoster in Portugal between 2000 and 2010","volume":"26","author":"Mesquita","year":"2013","journal-title":"Acta Med Port"},{"key":"10.1016\/j.jinf.2015.10.003_bib23","first-page":"1","volume":"5","author":"Servicio de Epidemiolog\u00eda","year":"2014"},{"key":"10.1016\/j.jinf.2015.10.003_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4321\/S1137-66272008000100006","article-title":"Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005\u20132006","volume":"31","author":"Garcia Cenoz","year":"2008","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.jinf.2015.10.003_bib25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annepidem.2005.12.002","article-title":"Gender as an independent risk factor for herpes zoster: a population-based prospective study","volume":"16","author":"Opstelten","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jinf.2015.10.003_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","article-title":"Disease burden of herpes zoster in Sweden\u2013predominance in the elderly and in women - a register based study","volume":"13","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","article-title":"Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany","volume":"14","author":"Ultsch","year":"2013","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jinf.2015.10.003_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1576-9887(11)70019-X","article-title":"Hospitalizaciones por herpes zoster y neuralgia postherp\u00e9tica en Catalu\u00f1a, 1998\u20132003","volume":"12","author":"Bayas","year":"2011","journal-title":"Vacunas"},{"key":"10.1016\/j.jinf.2015.10.003_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2015.10.003_bib30","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella-zoster virus in England and Wales","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2015.10.003_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00006454-200107000-00002","article-title":"Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease","volume":"20","author":"Coplan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2015.10.003_bib32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib33","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2015.10.003_bib34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/591132","article-title":"Hospitalizations to treat herpes zoster in older adults: causes and validated rates","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1471-2334-13-463","article-title":"Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)","volume":"13","author":"Morant-Talamante","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2015.10.003_bib36","series-title":"Informe del Estado de Salud de la Poblaci\u00f3n, Comunidad de Madrid","year":"2014"},{"key":"10.1016\/j.jinf.2015.10.003_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1017\/S0950268803008690","article-title":"Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia","volume":"131","author":"MacIntyre","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2015.10.003_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12889-015-1753-y","article-title":"Herpes zoster-associated mortality in Europe: a systematic review","volume":"15","author":"Bricout","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jinf.2015.10.003_bib39","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4065\/mcp.2011.0305","article-title":"Herpes zoster and postherpetic neuralgia surveillance using structured electronic data","volume":"86","author":"Klompas","year":"2011","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531500331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531500331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:22:27Z","timestamp":1759008147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344531500331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S016344531500331X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2015.10.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}